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Abstract
Backround: Epithelial-mesenchymal transition (EMT) changes polarized epithelial cells into migratory phenotypes
associated with loss of cell-cell adhesion molecules and cytoskeletal rearrangements. This form of plasticity is seen in
mesodermal development, fibroblast formation, and cancer metastasis.
Methods and Findings: Here we identify prominent transcriptional networks active during three time points of this
transitional process, as epithelial cells become fibroblasts. DNA microarray in cultured epithelia undergoing EMT, validated
in vivo, were used to detect various patterns of gene expression. In particular, the promoter sequences of differentially
expressed genes and their transcription factors were analyzed to identify potential binding sites and partners. The four most
frequent cis-regulatory elements (CREs) in up-regulated genes were SRY, FTS-1, Evi-1, and GC-Box, and RNA inhibition of the
four transcription factors, Atf2, Klf10, Sox11, and SP1, most frequently binding these CREs, establish their importance in the
initiation and propagation of EMT. Oligonucleotides that block the most frequent CREs restrain EMT at early and
intermediate stages through apoptosis of the cells.
Conclusions: Our results identify new transcriptional interactions with high frequency CREs that modulate the stability of
cellular plasticity, and may serve as targets for modulating these transitional states in fibroblasts.
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Introduction
Epithelial-mesenchymal transition (EMT) is a classic mecha-
nism of cellular plasticity [1,2]. EMT events fall into three
subtypes based on context: Type 1, involving primitive epithelial
cells transitioning to mesenchymal cells during embryological
formation of the early body plan [3,4]; Type 2, involving
secondary epithelial [5,6] or endothelial [7,8] cells transitioning
to tissue fibroblasts during fibrogenesis, and; Type 3, involving
epithelial carcinoma cells in primary nodules that transition to a
metastatic phenotype [9,10]. The subject of EMT in the kidney
has been reviewed recently [6,11,12].
Initiation of EMT in fibrosis is dependent on outside-in
signaling by transforming growth factor-b (TGF-b) [13,14] as
well as other effector molecules including ILK, EGF, and FGF-2
[6]. EMT transition results in the up-regulation of transcriptional
modulators such as CBF-A [15], Snail [16], Twist [17], HMG A2
[18], b-catenin [19], LEF 1, Zeb2/Sip1 [20] and Smad [21], the
loss of adherence molecules, and the gain of new moieties
important for cell movement [1,9]. The direct overexpression of
snail [22] or twist [23] classically induce EMT and fibrosis in adult
tissues, and the binding of CBF-A to the FTS-1 cis-regulatory
element (CRE) in the promoters of some of the prototypical EMT
genes serves as a key modulating event [15].
Sequence-specific binding of transcription factors is prerequisite
for transcriptional regulation through gene regulatory networks
[24,25,26,27,28] and CREs are essential for negotiating specific
recognition between regulatory factors and nucleotide sequences
[29,30]. Still, there is no clear pattern recognition for the
regulatory networks in the initiation and maintenance of the
molecular program of EMT. Here we characterize the gene
expression patterns of epithelia at different stages of transition by
DNA microarray using proximal tubular epithelial cells induced
with cytokines [14] and validated in vivo in a model of kidney
fibrosis [11]. Our results suggest that networks of CREs define the
binding of preferred transcription factors and their complexes to
drive pivotal genes in the EMT program.
Materials and Methods
Cell cultures and stimulation
The kidney proximal tubular cell line, MCT, was derived from
mice [31]. For initiation of EMT, epithelial cells were fed with a
low-serum medium overnight, and induced with 3 ng/ml TGF-b1
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were used as a control fibroblast cell line.
Unilateral urethral obstruction (UUO)
We followed the procedure as described earlier [15]. The
Institutional Animal Care and Use Committee (IACUC) at
Vanderbilt University approved all animal studies. Three-
month-old male Balb/c mice (Jackson Laboratories, Bar Harbor,
ME) were used and mice were monitored postoperatively. Both
fibrotic and contralateral kidneys were harvested at several time
points up to 7 days after surgery and snap-frozen in liquid
nitrogen. RNA was extracted from crushed frozen tissue by
homogenization in Trizol (Invitrogen, Carlsbad, CA) according to
manufacturer’s instructions. The expression pattern of selected
genes was monitored by qRT-PCR as described below.
Microarray analysis
Total RNA was collected from the cells at different time points
using Trizol (Invitrogen), converted to cDNA, and hybridized to
microarray slides using the Affymetrix Mouse GeneChip Mu-
430A Oligo Set (Affymetrix, Santa Clara, CA) at the Vanderbilt
University Microarray facility. To identify the common regulated
genes between transitioning epithelia and the fibroblast endpoint,
the pattern of differential expression at a given time point (time
point N versus time point 0), was compared with that of 3T3
fibroblasts versus time point 0 (non-induced epithelium). Data
were collected from three separate experiments for each time point
and subjected to analyses to satisfy criteria for statistical
significance and cutoff.
Data normalization, scoring, and analysis
Briefly, raw intensity data were background-subtracted using
maximum likelihood estimation and normalized to the baseline
array by two-dimensional variable reduction and approximation
(NVRA) method to remove systematic nonlinear noise between
paired arrays [32]. Sample sizes for microarray experiments are
generally small and may vary among treatment groups. We thus
used a rank-based differential expression method of analysis,
which takes advantages of unique multiple measurements per
transcript design implemented in Affymetrix chip arrays (see
Methods S1 for details). An absolute fold change of 1.75 was used
to select genes with differential expression. Venn diagrams were
compiled using an online tool (www.SmartDraw.com). Differen-
tially expressed genes were grouped according to their quintes-
sential functions using the Excel bioinformatics tool (http://www.
helsinki.fi/project/ritvos/GoCore/). Functional clustering of dif-
ferentially expressed genes was performed using DAVID Bioinfor-
matic Resources (NIAID, NIH). Pathway maps were derived as
follows: the differentially expressed genes and their log2 expression
ratios between untreated versus treated were imported into
PathwayAssist software (Ariadne Genomics, Rockville, MD) using
gene IDs supplied by Affymetrix annotation files. Pathways were
constructed using find only direct interactions between selected
entities option.
siRNA inhibition
Three pre-designed Stealth Select siRNAs
TM (Invitrogen,
Carlsbad, CA) for each targeted gene, were used for transfection
using Lipofectamine 2000 (Invitrogen) and pre-tested for levels of
RNAi by quantitative real-time PCR (qRT-PCR). The most
effective siRNAs were adopted for the study together with a
specificity control siRNA that did not suppress the target. The
levels of transcriptional repression were monitored by qRT-PCR
using D-Lux primers/probes (Invitrogen) at different time points
after transfection. For monitoring the effect of RNAi on the
process of EMT, parallel MCT cultures were transfected with
siRNA targeting a particular transcript or its specificity control
and 24 hours later one of the cultures was induced for EMT (see
above). RNA was extracted 6 or 18 hours after induction for qRT-
PCR analysis. In addition, separate cultures treated similarly, were
used as a source of total protein for Western blot analysis 18 hours
after EMT induction.
Western blot analysis
Blots were performed as previously described [15]. Our
previous experiments showed at different stages of EMT that the
expression of several housekeeping genes commonly used for
normalization, including GPDH and b-actin, vary over time as
described by others [33] and their use is not applicable [15].
Instead we used Coomassie blue staining of replicate gels as
loading controls. In preliminary experiments we stained mem-
branes after immunoblotting, before immunoblotting, or the gels
after transfer [34,35]. There were no substantial quantitative
differences between the stained protein bands using either of these
techniques. For this reason, the loading controls in the Western
blots here represent staining of replicate gels.
qRT-PCR analysis
Extracted total RNA from cell cultures was treated with DNAse
I, and converted by reverse transcription to single-stranded cDNA
using Superscript reverse transcriptase (Invitrogen, CA). Primers
and FAM labeled probes for the EMT marker genes were from
TaqMan Gene Expression Assays (Applied Biosystems, CA). The
primers and D-Lux probes for the siRNA- targeted transcription
factors were from Invitrogen. Quantitative PCR reactions were
performed in 96-well format using an Applied Biosystems 7900HT
Fast PCR System and Taqman Fast Universal Master Mix
(Applied Biosystems).
All qRT-PCR experiments were performed three times as
separate experiments and each biological replicate in each
experiment was run in triplicate, according to standard protocol
[15]. Data expressed as cycle threshold (Ct) values were
normalized to the amount of input cDNA and calculated as fold
change in comparison to control values using the Excel
bioinformatics tool and the formula [=power(2,-(xn-yn))], where
xn and yn are the positions of treatment and control. Data are
presented as means and standard deviations. Previous experiments
demonstrated that the expression of several common housekeeping
genes used for normalization change at different stages of EMT
and are not useful in this setting. Instead we adopted normaliza-
tion for qRT-PCR samples based on their optical density at
260 nm, which we [15] and others [36] have used successfully.
Normalization based on the total cellular RNA content is
increasingly used, as total cellular RNA is the ‘least unreliable’
method [37,38]. Equal amounts of RNA was used for the RT
reactions, the cDNA generated was again quantitated by UV,
diluted to equal absorbance as working samples, and then again
screened by UV to account for possible differences in dilution.
For experiments using cells transfected with CRE decoys, a one-
way ANOVA was used to assess the overall level of significance
across experimental inhibitors and control inhibitor for each time
point separately. The post hoc Bonferroni-corrected t-test was
used to compare mean differences between each of 4 experimental
inhibitors (siRNA or decoys) and their relevant controls whereby
ANOVA detects overall level of significance. All data analyses
were performed using SAS 9.1.3 (SAS Institute, Cary, NC); a
significance level of 0.05 was used for statistical inferences.
Transcriptional Control of EMT
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the 4 transcription factors were used to compile the transcriptional
network relationships presented in the text. For statistical
evaluation we used Student’s t-test with a Bonferroni adjustment
post hoc to assess differences between groups. Statistical analyses
were performed using R version 2.10.0 (http://www.r-project.org)
and 2-sided P values less than 0.05 were considered statistically
significant.
Identification and charting of cis-regulatory elements
For each time point (T6, T18 and T96), we selected groups of
up-regulated (expression value greater than 1.75) and down-
regulated (expression value less than 21.75) genes, then
performed a sequence of three analysis steps. For each gene,
the sequence of the promoter region was delineated as 1500 bp
upstream to 500 bp downstream (21500 to +500, total 2000 bps)
of the annotated TSS. Promoter sequences were annotated as
FASTA format and fed to TFM-Explorer [39], which interfaces
with TRANSFAC [40] to identify putative cis-regulatory elements
along the promoter sequences. TRANSFAC, the largest repos-
itory of experimentally validated transcription factor binding
sites, predicted CREs in the sequence limits mentioned based on
a start site of 0. The total counts for individual cis-elements were
tabulated for each gene group and then cis-regulatory elements
were sorted based on their frequencies across all time points.
With the top six most frequent, common cis-elements in each
gene group (up- or down-regulated), total numbers of their
occurrences were plotted at different time points. In the plot, the
total counts of respective cis-elements were shown as percentile of
their frequency in the total number of genes selected at that time
point.
Oligonucleotide decoys (Dumbbells)
Concatenated sequences with repeats identical to the four most
frequent cis-elements were synthesized (IDT, Coralville, IA) and
ligated as described [41]. They were transfected into MCT cells as
described above for siRNA.
Evi-1: ODN1: 59-tttatcttggctgtttaccttgtctgcttggtttttccaag, OD-
N2: 59-cagacaaggtaaacagccaagat aaaccgtctttttgacgg; FTS-1: ODN-
1: 59-tgattgatccttgattgatcctcttggtttttccaag, ODN2: 59-aggatcaatc
aaggatcaatcaccgtctttttgacgg; SRY: ODN1: 59-acttttgttttttacttttgttt-
tttcttggtttttccaag, ODN2: 59-aaaaaacaaaagtaaaaaacaaaagtccgtcttt-
ttgacgg; GC-Box: ODN1: 59-ggccccgccccggtgccccgcccct gcttggtttt-
tccaag, ODN2: 59-accggggcggggccaccggggcggggccccgtctttttgacgg;
DB-control: ODN1: 59- actgactgactgactgactgactgcttggtttttccaag,
ODN2: 59- cagtcagtcagtcagtcagtcagtccgtctttttgacgg.
Apoptosis of cells transfected with the oligonucleotide decoys
was evaluated by the In Situ cell Death Detection kit (Roche
Diagnostics, Mannheim, Germany) according to manufacturer’s
instructions.
EMSA
EMSA was performed as described previously [15]. Nuclei
were purified from cultured cells using the Nuclei EZ Prep
isolation kit (Sigma-Aldrich, St. Louis, MO) according to
manufacturer’s instructions. Nuclear extracts were prepared in
400 mM KCl buffered with 20 mM HEPES pH 7.9 supple-
mented with a cocktail of proteinase inhibitors (Sigma-Aldrich).
The protein extracts were brought down to 100 mM KCl by
dialysis and the protein content of the supernatant was estimated
using the DC Protein assay (BioRad, Hercules, CA). For
competition analyses, protein was pre-incubated with unlabeled
oligonucleotides.
Results
Network patterns of transcription during EMT
The transcriptomes of tubular epithelial cells undergoing EMT
to form fibroblasts and of control fibroblasts relative to non-
induced epithelium were interrogated by DNA microarray at three
time points: early (6 hours), intermediate (18 hours) and late
(96 hours) [14]. Samples after 48 hours of EMT were also
investigated by DNA microarray and showed that the gene
expression pattern is intermediate between 18 and 96 hours (data
not shown). EMT is a continuum and there is no definitive
timepoint at which drastic deviations occur. Divergence in the
gene expression pattern is observed as early as 6 hours after
induction and morphological changes appear gradually over
several days. After 18–24 hours, cells start to assume a more
ellipsoidal appearance and detach from sister cells. Their numbers
gradually increase and at 96 hours the fibroblast morphology
totally prevails. Venn diagrams of up or down-regulated genes at
each time point illustrate the number of genes unique or shared
between time points (Figure 1). The number of up-regulated genes
(A) during the first 6 to 18 hours (dark blue) is considerably higher
than down-regulated genes (B) from the same time period. More
than 60% of all differentially expressed genes are up-regulated
(Table S1), with the highest percentage (72%) in the first 6 hours
maintained through 18 hours (63%). This percentage strikingly
declines to 35% at 96 hours, which marks the end of the transition
to fibroblasts [15].
The transcriptome of newly forming fibroblasts compared to
control fibroblasts (Figure 1C) share a large number of
differentially expressed genes (893) that represent 80% of all
changed genes and 54% of the genes found in fibroblasts.
Figure 1D illustrates the hierarchical clustering of EMT genes
using a scale normalized by non-parametric variable reduction
and approximation for differentially expressed genes that are
statistically different from non-induced controls (P,0.01) [32].
This hierarchical clustering aggregates the changes at various
stages of EMT with the majority of up-regulated genes (red) during
the first 18 hours of induction and a noticeable increase in down-
regulated (green) or unchanged (black) genes at 96 hours.
Validation of expected EMT markers in cells and a model
of tissue fibrosis
We employed a classical model of kidney fibrosis following
urethral obstruction [1]. Based on the EMT literature
[3,15,21,42,43], we also selected marker genes (transcription
factors: Snail1, Snail 2, Twist 1, Hmga2, CBF-A, KAP-1, and Ets and
non-transcription factors: FSP1, moesin, annexin 8, PDGF, vimentin,
aSMA, and E-cadherin) to monitor transition using both qRT-PCR
and protein expression [15,43] . The test samples used to generate
the microarray data were probed for mRNA expression
(Figure 2A,C) and protein for immunoblotting was obtained at
18 hours after induction of EMT (Figure 2E). The results confirm
expected differential expression of EMT markers. The relevance
of the cell culture system was also validated by monitoring the
expression of the same gene set in mouse kidneys with fibrosis
(Figure 2, C and D), where most interstitial fibroblasts derive from
EMT [Iwano, 2002 #35;Zeisberg, 2010 #472;Zeisberg, 2010
#439]. The similar expression pattern of expected EMT markers
in vitro and in vivo confirms their relevance to transition from
epithelial cells to fibroblasts.
Organization of the molecular networks encoding EMT
Hierarchical clusters of EMT genes were grouped according
to their known functions using the DAVID Bioinformatics
Transcriptional Control of EMT
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Genomics). The most populated clusters include genes involved
with the cell cycle, cell adhesion, endoplasmic reticulum,
extracellular matrix, transcription factor, inflammation, and
cytoskeleton (Figure S1). The predominant functions in each
cluster at each stage of the transition are defined in Table S2.
The major networks activated in EMT at early and intermediate
stages are related to the cellular inflammatory response,
regulation of cell growth and proliferation, cell cycle activation,
stress fiber reorganization and remodeling of the extracellular
membrane, and change to a motile phenotype. Regulation of
cell survival, down-regulation of cell cycle progression, and
suppression of inflammatory response characterize the late stage
at 96 hours.
Figure 1. Distribution and clustering of differentially expressed genes during EMT progression. (A–C) Venn diagrams. The number of
genes changed at each stage is indicated and the various stages are colored as follows: red- 6 hours; violet-18 hours and yellow- 96 hours. (A) Up-
regulated, (B) Down-regulated. Labeled with green are genes shared by all three stages; genes shared between two stages are labeled as shown. (C)
Genes with changed expression in EMT and in NIH 3T3 fibroblasts in comparison to naı ¨ve MCT. (D). Hierarchical clustering of the genes changed at
various stages of EMT. Red- up-regulated, green- down-regulated; black- not changed. The color bar at the top displays the levels of differential
expression based on their relative expression levels and statistical significance (see Methods).
doi:10.1371/journal.pone.0025354.g001
Transcriptional Control of EMT
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highlight the expected relationships between differentially ex-
pressed genes and include both time-dependent genes and those
modulated throughout the process (Figure S2). Although these
interactive maps are particularly useful for interrogating signals
within a single network, they become quite complex when
multifaceted cell remodeling takes place. This complexity for
EMT in the first 6 hours is very obvious and gradually attenuates
until only a few interacting pathways are operative at 96 hours.
These pathway diagrams suggest transcriptional control of EMT
can be understood as a set of interdependent and changing
networks.
CREs as probes for EMT networks
As highly conserved regulatory elements dominate morpholog-
ical changes during embryological development [44,45,46,47], we
also probed various transcriptional relationships between EMT
transcription factors and their binding to cis-response elements
(CREs) among involved promoters. We recovered the CREs of all
up or down-regulated genes and compiled the most frequent CREs
at each time point of EMT using TRANSFAC [40], the largest
repository of experimentally validated transcription factor binding
sites.
The total number of the CREs was plotted as a percentage of
their frequency among the total number of genes at a particular
time point (Table S1 and Figure S3). As up-regulated genes are the
majority of all changed genes, the most frequent CREs among all
up-regulated genes are shown in Figure S3A, those of up-regulated
transcription factors (Figure S3B), and the most frequent CREs
among down-regulated genes (Figure S3C); the down-regulated
transcription factors represent a small number of all factors
(Scand1, Taf6l, Tsc22d3, Zipro1, Hoxb1 at 6 hours; Tcf2 at 18 hours,
and; Irf8, Lmcd1, and Pax8 at 96 hours) and the most frequent
CREs in the totality of up-regulated genes are similar to those of
up-regulated transcription factors. The percentage number in the
plots exceeds 100% as some CREs are repeated more than once,
forming clusters among promoter sequences. The results suggest
that distribution of the most frequent CREs at any given time point
is non-random.
The most frequent CREs among all up-regulated genes are SRY,
SP1, Evi-1, GC-box, Elk-1, and FTS-1. FTS-1 is already recognized
as a master regulatory element in EMT [15]. Interestingly, the
percentage of SRY, and to a lesser extent SP1, is highest in the
genes up-regulated at the onset of EMT and then both decline
rapidly, while the percentages of FTS-1 remain active throughout,
GC-box, Elk-1 and Evi-1 decline by 35–60%. The contribution of
RREB1 and GC-box among transcription factors, however,
increases with EMT over time. This pattern of differential
representation over time is similar in the up-regulated transcrip-
tion factors (Figure S3B) with the exception of GC-box, which
increases in percentage from 18 to 96 hours. The overall similarity
in frequency of CREs between all genes and the cluster of up-
Figure 2. The EMT marker genes are also differentially expressed when monitored by qRT-PCR and immunoblotting. (A, B) in MCT
cells induced to EMT; (C, D) in the fibrotic kidney. The mean results from three independent replicates are expressed as fold change compared to the
expression in non-induced naı ¨ve MCT cells. (E). Immunoblotting of total protein extracted from MCT cells induced to EMT after 18 hours, or naı ¨ve
controls (C). The loading controls for the Western represent Coomassie staining of replicate gels as the expression of housekeeping genes is not
stable throughout EMT.
doi:10.1371/journal.pone.0025354.g002
Transcriptional Control of EMT
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functional clusters in EMT.
A similar trend of time-dependent differential representation for
the most frequent CREs was found in down-regulated genes, where
the most frequent CREs are CREB, RREB1, USF, GC-Box, and SP1
(Figure S3C). It is interesting that both GC-Box, and SP1, which
peak at 18 hours, are also listed as most frequent of the up-
regulated genes. This finding may reflect their propensity to
partner with multiple co-factors that modulate transcription as
heterologous complexes.
Knockdown of transcription factors regulated by high
frequency CREs
The finding that particular CREs prevail at different stages of
transition with a statistically significant distribution at given time
points raises the question of how these changes relate to the
differential regulation of the EMT transcriptome. The transcrip-
tion factors up-regulated in EMT are displayed in Table S3
together with their most frequent CREs. Underlined are four high
CRE frequency transcription factors that were chosen for further
study for their relevance to TGF-b-induced EMT (Atf2 [48,49],
SP1 [50,51,52], Klf10 [53,54], and Sox11 [55]). All four
transcription factors are induced within 6 hours and remain up-
regulated at 18 hours with two, Klf10 and Sox11, being up-
regulated throughout EMT. The basal levels of expression of the
four transcription factors are also higher in control fibroblasts
compared to non-induced tubular epithelial cells (Figure 3A).
These four transcription factors are also up-regulated to varying
extent in fibrotic kidney (Figure 3B).
We next studied the effect of RNA inhibition (siRNA) of these
four transcription factors on the expression of the EMT marker
genes described earlier. Epithelial cells were transfected with the
appropriate target siRNA or a specificity control, and a day later
were induced to EMT for 6 hours. Only the levels of expression of
EMT marker genes having binding sites for the corresponding
transcription factors in their promoters were monitored
(Figure 4C–G). The targeted inhibition of each of the four
selected transcription factors suppresses the expression of corre-
sponding genes to different degrees. Klf10 binding sites are
represented in most of the genes studied and its inhibition
negatively affects the expression of the selected EMT markers as
well as the other three factors under study, Sox11, Atf2, and SP1
(Figure 3C and 3D). The inhibition of Sox11, Atf2, and SP1 also
negatively affects the expression of genes having their correspond-
ing binding sites (Figure 3E–G).
Alternatively, the expression of FSP1, vimentin,a n dHmga2,
having Klf10 binding sites, are not affected by its inhibition. FSP1
has binding sites for Atf2 as well, but again is not affected by its
inhibition (Figure 3E). As was pointed out earlier [15], the
transcriptional complex, CBF-A/KAP1/FTS-1, seems to effective-
ly regulate FSP1 activation alone. The expression at the protein
level generally follows changes in the corresponding levels of
mRNA with some exceptions (Figure 3I). EMT marker genes that
do not have binding sites for some CREs are down-regulated by
their inhibition, for example Snail1 and Sox11, Hmga2 and Atf2,
FSP1 and SP1. This apparent disparity cannot be explained solely
by differences in the protein half-life because it also exists at the
level of transcription and thus implies the existence of
overlapping CRE networks. Despite their pronounced effect on
the expression of the EMT marker genes, knockdown of any of
the four transcription factors postpones transition to fibroblast
phenotype by 5–6 days (data not shown), but does not abrogate
EMT.
Knockdown of high frequency CREs leads to apoptosis
and attenuation of EMT
The finding that knockdown of each of the four above
transcription factors modulates target EMT genes and slows down
phenotypic transition suggests the most frequent CREs contribute
to a highly regulated transcription network.
To interrogate this notion further we blocked each of the four
most frequent CREs (SRY, Evi-1, GC-Box, and FTS-1) among up-
regulated genes to establish their effect on the stability of
transitional cells during the expression of EMT genes. To this
end, we designed decoy oligodeoxynucleotides (ODN) for SRY,
Evi-1, GC-Box, and FTS-1 as well as irrelevant controls to known
CREs [56,57,58]. We hypothesized that this approach would
interfere with an entire set of transcription factors and their
associated binding-proteins. Each decoy oligonucleotide consists of
two repeating CREs ligated at both ends for nuclease protection in
a dumbbell structure (Figure 5A) [41]. Radiolabeled forms of each
of the selected CREs generate complexes in EMSA that are more
pronounced with nuclear protein from EMT-induced tubular cells
(Figure 4B). The activity of the decoys was established by
competition using 10 to 100-fold molar excess to challenge
complexes formed with different CREs. Competition with
heterologous decoys (Figure 4C) established that FTS-1 competes
Evi-1 and GC-Box, while Evi-1 competes SRY and SRY competes
FTS-1 albeit partially.
EMT normally protects most transitioning cells from apoptosis
[46,59,60], perhaps through the eventual activation of Snail [61]
or Twist [47]. Approximately 10–15% of cells, however, become
apoptotic immediately after induction of EMT with TGF-b
(Figure 6, induced non-transfected control) in accordance with the
known effect of this cytokine on mammalian cells [62]. However,
the CRE decoys transfected into tubular epithelial cells initiate
apoptotic cell death visible after 24 hours of EMT (Figure 5). This
substantial apoptotic response is paralleled by modulation in the
expression pattern of the EMT markers as measured by qRT-PCR
and Western blotting (Figure 6). Neither control decoys in induced
cells, nor decoys transfected in non-induced cells engender such a
strong apoptotic response.
To test the notion that the most frequent CREs belong to a
network we studied the expression of the marker genes in response
to all blocked CREs, present or not present on their promoters. As
the levels of mRNA encoding the marker genes change during
EMT (Figure 2), we monitored their expression at two time points
with the highest number of up-regulated genes 6 and 18 hours
(Figure 6A and 6B). All four decoys, but not the control, inhibit
marker expression to varying extent, which is time- and sequence-
specific.
At the onset of EMT (Figure 6A), knockdown of the GC-Box has
the most pronounced effect on the mRNA levels across the board,
replaced by Evi-1 as a dominant suppressor at 18 hours. Similarly,
SRY, which is second to GC-Box in its inhibition at the onset, is
replaced by FTS-1 later. This finding verifies the dynamic state of
transcriptional networks during EMT. Another observation is that
inhibition of some CREs affects the expression of genes that do not
share that promoter element. This is the case with Snail2 (Slug) not
having FTS-1in its adjacent promoter [14], but being affected by
its inhibition (Figure 6A and B). The importance of the FTS-1
transcription complex for induction and propagation of EMT was
reported earlier [14]. We assume that as FTS-1 also competes GC-
Box complexes in EMSA (Figure 4C), its inhibition would also
affect genes having this GC-Box in their promoter. Indeed, the
Snail2 (Slug) promoter contains this element. Similarly, inhibition
of Evi-1 affects negatively the expression of CBF-A and Hmga2,
genes that do not have this CRE, but have SRY, which is competed
Transcriptional Control of EMT
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e25354Figure 3. siRNA inhibition of the four up-regulated in EMT transcription factors alters the expression of the marker genes. (A)
Expression levels of Klf10, Atf2, Sox11, and SP1 in EMT and (B) during UUO-induced fibrogenesis. Effects of their RNAi on the expression of EMT
markers having the corresponding CREs (C–G, qRT-PCR; H, Western blot). The mean results from three independent replicates are expressed as fold
change compared to the expression in naı ¨ve MCT cells (A), contralateral kidney (B), or specificity control (C–G). C and D. RNAi of Klf10 modulates the
expression of most of the EMT marker genes. (E–G). Modulation of the expression of the marker genes under RNAi of Atf2 (E), Sox11 (F), and SP1 (G).
(H). Expression of the EMT markers at the protein level. The loading controls for the western blot represent Coomassie staining of replicate gels.
doi:10.1371/journal.pone.0025354.g003
Figure 4. Oligodeoxynucleotide decoys (ODN) compete transcription factors for binding to their respective CREs and inhibit
formation of complexes between CREs and nuclear protein. (A) Structure of the ligated at both ends decoys (dumbbells). DB-control- random
oligodeoxynucleotide used as a negative control. (B) and (C). EMSA of radiolabelled CREs forming complexes with nuclear protein from induced (+)o r
non-induced cells (2) that are competed by their respective decoys (B) or heterologously by others (C).
doi:10.1371/journal.pone.0025354.g004
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obvious at the protein level (Figure 6C) and is most likely caused
by formation of heterologous transcription complexes in which at
least one of the partners recognizes a specific CRE. The propensity
of transcription factors to recognize and bind heterologous CREs
needs also to be taken into account (Figure 6D).
Based on data collected and statistically evaluated from qRT-
PCR at two timepoints of EMT, we compiled a graph expressing
the order at which the particular decoys affect the overall
expression of EMT markers (Figure 7). Measured by the inhibitory
effect on mRNA expression, the order of preference changes with
the progression of EMT. Notably, GC-Box that is most efficient at
the onset of EMT (A) is rendered most ineffective after 18 hours
and is replaced by Evi-1 (B). Taken together, our results imply the
existence of a network of transcriptional control that is based on
changing the binding preferences of crucial transcription factors at
different stages of the transition. Using these data we compiled a
table of the most effective CREs in the regulation of the EMT
markers at two time points, 6 and 18 hours (Table S4). The table
lists the most effective decoys in down-regulating the selected
markers. Together with the observed variation in competition all
data suggest that the four CREs are mutually dependent and to
some extent, interchangeable. Statistical evaluation of the effects of
their inhibition on the mRNA expression of their target genes
produced a list of likely hierarchical interrelationships exemplified
in Figure 8.
Discussion
Regulatory networks in EMT
EMT in adult cells confers the property of movement in once
stationary epithelial cells [14,47,59] through a variety of trans-
criptional networks forming fibroblasts [1]. Increased transcrip-
tional gene activity prevails in EMT for at least 18 hours after
which it becomes down-regulated by 96 hours. This remodeling of
the transcriptome begins before morphological changes are
apparent [15]. Variations in the ratio of up-regulated genes
during the time course of EMT suggest that key gene clusters are
dynamic events with transcription of most up-regulated genes
switching on and off during transition, while down-regulated genes
are generally silent throughout the transition interval. Approxi-
mately 20% of all changed genes in transitioning epithelia are not
shared with control fibroblasts, which may reflect the unique
transcriptional patterns of parental cells [1] or the axial variability
in fibroblast subpopulations [63].
The functional clustering of differentially expressed genes
suggests a complex network of regulatory pathways execute cell
remodeling as a hierarchy. The signaling networks activated
Figure 5. Inhibition of the most frequent CREs by their decoys leads to apoptosis of cells induced to EMT. Induced (+) and non-induced
(2) cells respond differently to the effects of the decoys after 24 hours. Apoptosis was evaluated using the TUNEL technology (see Materials and
Methods). Magnification 406. Inset: quantitative evaluation of the apoptotic events. Control: non-transfected, but induced to EMT cells; DB-C: cells
transfected with the DB-control decoy.
doi:10.1371/journal.pone.0025354.g005
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and intrinsically involve MAP kinases leading to activation of other
transcription factors [64]; EGF action is an important modulator
of TGF-b action (in preparation). Our finding that the pattern of
expression of in vitro transcriptional genes is similar to a classical in
vivo model of kidney fibrosis validates the results of the DNA
microarrays.
Regulation of gene expression through transcription
factor binding sites
The importance of cis-regulatory modules for gene regulation as
a key component of gene regulatory networks has been recently
been stressed [30,65] and numerous efforts to comprehend the
regulatory networks through transcription factor binding sites [28]
have been made in relation to development [25,66,67] and
evolution [44]. By a combination of ChIP assay, expression
profiling, and gene knockdown Kubo et al. were able to reveal the
cis-regulatory networks during embryonic development of am-
phibians [67].
Mapping the CREs of the up-regulated gene clusters at various
stages of EMT is evident in Table S3, which lists the up-regulated
transcription factors during the first 18 hours and throughout
EMT. Their importance was further tested by suppression of four
selected transcription factors that contain the most represented
CREs in their promoters. They were selected also on the basis of
their functions as listed in NCBI databank as follows: the activating
transcription factor-2 (ATF2), is modulated by TGF-b and
operates as a key regulatory molecule in cell growth, Sp1
participates in heterologous complexes with other transcription
factors to regulate transcription of a variety of genes. Kru ¨ppel-like
factor 10 (Klf10) is known to antagonize TGF-b signaling, while
Sox11, SRY (sex determining region Y)-box 11 is involved in the
regulation of cell fate decisions. The selective inhibition of the four
normally up-regulated transcription factors in EMT brings
changes in the expression pattern of the EMT markers and slows
down the transition. Down-regulation of any of the four
transcription factors also affected the expression of genes not
having obvious binding sites while genes that have the appropriate
CREs were not affected by RNA inhibition of the corresponding
transcription factors. The apparent promiscuity in the alternative
binding sites for these transcription factors as shown in Figure 6D
emphasizes the complexity of the regulation.
Figure 6. Decoys of the most frequent CREs modulate the expression of EMT marker genes. (A) after 6 and (B) after 18 hours transition.
The mean results from three independent replicates are expressed as fold change compared to the expression in non-induced MCT cells. The extent
of modulation is specific for each decoy and affects their corresponding CREs, but reveals also a heterological type of inhibition, more obvious at the
protein level (C) that underscores the ubiquitous nature of binding specificity (D). The loading controls for the western blots (C) represent Coomassie
staining of replicate gels. The transcription factors identified to have specificity to the most frequent CREs in addition to their principal binding sites
(D) are identified using TFM-Explorer (http://bioinfo.lifl.fr/TFM/TFME/) and rVista (http://rvista.dcode.org/).
doi:10.1371/journal.pone.0025354.g006
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PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e25354Figure 7. Stage-specific modulation of the expression of EMT markers by inhibition of the most frequent CREs. The graph is based on
statistical evaluation of the inhibition of the expression of EMT markers and depicts the most effective inhibitory decoys as measured by qRT-PCR for
time points 6 hours (A) and 18 hours (B). Note change of binding preferences with EMT progression. C: DB-control decoy.
doi:10.1371/journal.pone.0025354.g007
Figure 8. Schematic representation of the complex transcriptional networks in EMT based on the expression of selected EMT
markers under RNAi of the four transcription factors. The genes are grouped according to the overall effect on their targets, down- or up-
regulation. On top are factors causing the most overall effect, which decreases towards bottom. Red arrows mark upregulating events; green arrows
represent downregulation. The density of arrows is a measure of the strength of regulation according to the statistical evaluation. Twist is shown as a
reference for its promotional effect on EMT as described elsewhere, although it was not an object in this study.
doi:10.1371/journal.pone.0025354.g008
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and propagation of EMT
The oligonucleotide decoys designed to block the most represented
CREs in cells induced to EMT compete with the transcription factors
and block their function [68,69]. Introduction of any of the four
decoys into the epithelial cells affects irreversibly their ability to
undergo transition in favor of substantial apoptosis. This is a specific
effect, as control decoys do not elicit such response. Taking into
a c c o u n tt h a tt h ef o u rCREs were selected for inhibition as being most
frequent in the promoters of up-regulated transcription factors, it is
likely their blockage disrupts the transcriptional networks activated to
carry out EMT. This conclusion is supported by data showing
considerable down-regulation of the EMT marker genes and their
encoded proteins by blockage of any of the four CREs. As negative
regulation of apoptosis is one of the predominant functions in the
early stages of EMT to allow for cell growth and division (Table S2)
disruptionof such regulatory networks wouldalso negate this function
to enable apoptosis.
Another interesting observation is the change in order of
representation of the most frequent CREs during the transition
from 6 to 18 hours (Figure 7). This likely reflects change of
preferences for the transcription factors and their complexes
involved in propagation of the transition. It is difficult to ascribe
each transcription factor to a particular CRE as their binding
preferences are ubiquitous and vary in the context and timing of
various regulatory networks [70]. In addition, transcription factors
that do not have specificity for a particular CRE may bind as a
complex with another factor specific to the site and thus exert a
combined effect on expression of a given gene. Such variability
may be necessary in complex processes as EMT in which many
interdependent regulatory networks with many transcription
factors are involved, as exemplified by Figure S2.
The molecular program of EMT involves intricate networks of
dynamic signaling that change from induction to progression until
transition reaches a steady state. The complexity of the regulation
involved in EMT is highlighted by the interchanging preferences of
the transcription factors to CREs and presents a challenge to
understanding the role of given transcription factor in a particular
network. For this reason monitoring the most frequent binding sites
of the transcription factors involved in a particular process offers an
alternative approach to comprehend complex regulatory networks.
Ourresultsimplytheexistenceofatranscriptionregulatorynetwork
with interdependent regulation through variations of binding
preferences to selected CREs and by the propensity to form
heterologous transcription factor complexes. Like many other
networks [61], the regulatory networks in EMT are most likely
executed by dynamic and context-dependent formation of tran-
scription admixtures targeting interchangeable CREs.
In an effort to unravel the transcriptional regulatory network in
EMT, we applied an integrative approach combining DNA
microarray with computational biology that generates a compre-
hensive view of the regulatory interactions at a genome-wide scale.
This approach has lead to the creation of new web-based tools [71].
Supporting Information
Figure S1 Functional clustering in EMT at the various
stages studied. Genes are represented by their symbols on the
right and by accession numbers (left). Up-regulated: red, down-
regulated: green and unchanged: black. Some genes with multiple
functions participate in more than one cluster.
(TIF)
Figure S2 Regulatory pathway diagrams of differential-
ly expressed genes at the three EMT stages studied. Red:
up-regulated, green: down-regulated. Note the complexity of the
interacting networks at the 6 hour that become more simplistic as
the transition progresses.
(TIF)
Figure S3 Most frequent cis elements in the promoters
of all changed during EMT genes at the three timepoints
studied. The total counts of respective cis-elements are shown as
percentile of their frequency in the total number of genes selected
at that time point. (A). All up-regulated. (B). Transcription factors
up-regulated during the transition. (C). All down-regulated. Note
the changes in frequency of CREs with EMT progression. (D).
Most frequent CREs of the four transcription factors selected for
further study.
(TIF)
Table S1 Summary of differentially expressed genes.
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Table S2 Major regulatory networks in EMT.
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Table S3 Transcription factors upregulated in EMT
and their most repeated CREs. Early and intermediate
stages (6–18 hours) and throughout the transition (6–
96 hours).
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